Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J ECT. 2011 Mar;27(1):11–17. doi: 10.1097/YCT.0b013e3181f41ea3

TABLE 1.

Patient Baseline Characteristics

Baseline Patient Characteristics Enrolled (N=5) Mean (s.d.)
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Completers 4 Yes Yes Yes No Yes
Schizophrenia Diagnosis 4 Yes Yes Yes Yes
Schizoaffective Bipolar Type 1 Yes
Deficit Syndrome 4 Yes No Yes Yes No
History Depression 4 Yes No Yes Yes Yes
History suicide attempt 1 No No No No Yes
History substance abuse 2 Yes No No No Yes
Number women 2 Male Female Female Male Male
Age 27.6 (2.2) 26 34 30 24 24
Age of psychosis onset 18.8 (2.0) 19 14 25 19 17
Years of Education 13.2 (1.2) 12 17 11 12 14
Chlorpromazine equivalents 412.8 (74.6) 550 300 600 280 300
Number medications 2.8 3 2 1 5
Number medication types 2.4 (0.6) 2 2 1 3 4
Typical antipsychotic N=3 1 1 1
Atypical antipsychotic N=3 1 1 1 1
Anticholinergic N=2 1 1
Antidepressant N=2 1 1
Mood stabilizer N=1 1
Benzodiazepine N=1 1
Other N=1 1
Simpson Angus Rating Scale 1.4 (0.6) 1 3 2 1
PANSS
 Positive 16.2 (2.6) 23 19 11 17 11
 Negative 28.8 (2.6) 32 28 33 31 20
 General 36.6 (3.9) 46 42 26 36 33
 Total 81.6 (7.4) 101 89 70 84 64
HAM-D (17 item) 9.4 (2.8) 7 12 4 18 6
SAS 59.8 (10.8) 68 67 49 69 47
CGI 5.0 (0.7) 6 6 4 6 3
GAF 47.0 (4.2) 40 40 50 45 60
Motor Threshold 56.6 (7.7) 52 37 76 68 50

PANSS, Positive and Negative Syndrome Scale; HAM-D, Hamilton Depression Scale; CGI, Clinical Global Impressions; GAF, Global Assessment Factor; SAS, Social Adjustment Scale.